Update of TTD: Therapeutic Target Database
- PMID: 19933260
- PMCID: PMC2808971
- DOI: 10.1093/nar/gkp1014
Update of TTD: Therapeutic Target Database
Abstract
Increasing numbers of proteins, nucleic acids and other molecular entities have been explored as therapeutic targets, hundreds of which are targets of approved and clinical trial drugs. Knowledge of these targets and corresponding drugs, particularly those in clinical uses and trials, is highly useful for facilitating drug discovery. Therapeutic Target Database (TTD) has been developed to provide information about therapeutic targets and corresponding drugs. In order to accommodate increasing demand for comprehensive knowledge about the primary targets of the approved, clinical trial and experimental drugs, numerous improvements and updates have been made to TTD. These updates include information about 348 successful, 292 clinical trial and 1254 research targets, 1514 approved, 1212 clinical trial and 2302 experimental drugs linked to their primary targets (3382 small molecule and 649 antisense drugs with available structure and sequence), new ways to access data by drug mode of action, recursive search of related targets or drugs, similarity target and drug searching, customized and whole data download, standardized target ID, and significant increase of data (1894 targets, 560 diseases and 5028 drugs compared with the 433 targets, 125 diseases and 809 drugs in the original release described in previous paper). This database can be accessed at http://bidd.nus.edu.sg/group/cjttd/TTD.asp.
Figures
Similar articles
-
The Therapeutic Target Database: an internet resource for the primary targets of approved, clinical trial and experimental drugs.Expert Opin Ther Targets. 2011 Aug;15(8):903-12. doi: 10.1517/14728222.2011.586635. Epub 2011 May 28. Expert Opin Ther Targets. 2011. PMID: 21619487 Review.
-
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery.Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. doi: 10.1093/nar/gkr797. Epub 2011 Sep 24. Nucleic Acids Res. 2012. PMID: 21948793 Free PMC article.
-
Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information.Nucleic Acids Res. 2016 Jan 4;44(D1):D1069-74. doi: 10.1093/nar/gkv1230. Epub 2015 Nov 17. Nucleic Acids Res. 2016. PMID: 26578601 Free PMC article.
-
Trends in exploration of therapeutic targets.Drug News Perspect. 2005 Mar;18(2):109-27. doi: 10.1358/dnp.2005.18.2.886480. Drug News Perspect. 2005. PMID: 15883620 Review.
-
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.Nucleic Acids Res. 2018 Jan 4;46(D1):D1121-D1127. doi: 10.1093/nar/gkx1076. Nucleic Acids Res. 2018. PMID: 29140520 Free PMC article.
Cited by
-
In silico search of energy metabolism inhibitors for alternative leishmaniasis treatments.Biomed Res Int. 2015;2015:965725. doi: 10.1155/2015/965725. Epub 2015 Mar 30. Biomed Res Int. 2015. PMID: 25918726 Free PMC article.
-
A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment.PLoS One. 2012;7(2):e31968. doi: 10.1371/journal.pone.0031968. Epub 2012 Feb 20. PLoS One. 2012. PMID: 22363777 Free PMC article.
-
Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology.Evid Based Complement Alternat Med. 2022 Sep 9;2022:5765233. doi: 10.1155/2022/5765233. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36118098 Free PMC article.
-
In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date.J Ethnopharmacol. 2012 Apr 10;140(3):526-34. doi: 10.1016/j.jep.2012.01.041. Epub 2012 Feb 2. J Ethnopharmacol. 2012. PMID: 22326356 Free PMC article. Review.
-
Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target.Front Pharmacol. 2018 Oct 31;9:1245. doi: 10.3389/fphar.2018.01245. eCollection 2018. Front Pharmacol. 2018. PMID: 30429792 Free PMC article.
References
-
- Ohlstein EH, Ruffolo RR, Jr, Elliott JD. Drug discovery in the next millennium. Annu. Rev. Pharmacol. Toxicol. 2000;40:177–191. - PubMed
-
- Zambrowicz BP, Sands AT. Knockouts model the 100 best-selling drugs–will they model the next 100? Nat. Rev. Drug Discov. 2003;2:38–51. - PubMed
-
- Zheng CJ, Han LY, Yap CW, Ji ZL, Cao ZW, Chen YZ. Therapeutic targets: progress of their exploration and investigation of their characteristics. Pharmacol Rev. 2006;58:259–279. - PubMed
-
- Golden JB. Prioritizing the human genome: knowledge management for drug discovery. Curr. Opin. Drug Discov. Dev. 2003;6:310–316. - PubMed
-
- Imming P, Sinning C, Meyer A. Drugs, their targets and the nature and number of drug targets. Nat. Rev. Drug Discov. 2006;5:821–834. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials